This website is intended for US healthcare professionals only

US Medical Affairs

Congress Presentations

Stay informed about the latest scientific and medical research from Axsome.

Diamond Headache 2026

Lake Buena Vista, Florida | July 16 - 17, 2026

Symbravo® | Migraine

Comparative Efficacy of Symbravo® Versus Gepants for Acute Treatment of Migraine: A Network Meta-Analysis

View / Download

Symbravo® | Migraine

Symbravo® (MoSEICTM meloxicam and rizatriptan) for the Acute Treatment of Migraine: Posthoc Composite Efficacy and Return to Function Endpoint Analysis from MOMENTUM

View / Download
footer graphic

This site contains scientific information about investigational compounds and/or information about products and/or uses that have not been approved by the US Food and Drug Administration. The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.

AXSOME, AUVELITY, SUNOSI, SYMBRAVO and their logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.

© 2026 Axsome Therapeutics, Inc. All rights reserved. One World Trade Center, New York, NY 10007